Regent Pacific Group Limited (HKG:0575)

Market Cap	288.90M +241.8%
Revenue (ttm)	6.54M +535.9%
Net Income	-32.00M
EPS	-0.14
Shares Out	291.82M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	156,996
Average Volume	54,280
Open	0.9700
Previous Close	1.0100
Day's Range	0.8800 - 0.9900
52-Week Range	0.3800 - 1.2400
Beta	1.35
RSI	50.08
Earnings Date	Mar 27, 2026

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholog...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 17
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0575

Financial Performance

In 2024, Regent Pacific Group's revenue was $719,000, an increase of 147.08% compared to the previous year's $291,000. Losses were -$4.48 million, -82.11% less than in 2023.

Financial numbers in USD